J-STAR Research, Inc. was founded in 1996 by Dr. Andrew Thompson, formerly from Merck Process Research. The company has amassed an impressive client base of large pharmaceutical and biotechnology companies who have found that the industrial experience, technical expertise and dependability at J-STAR are unmatched in the industry.

Regis Technologies' mission is to be the recognized leader in the manufacture of active pharmaceutical ingredients and intermediates under GMP. We are the organic synthesis, drug development partner for U.S. pharmaceutical and biotech companies. Expediting new drugs to market enhances quality of life, saves lives, and creates value for our customers, employees, and shareholders.

Apredica provides preclinical contract testing services for the evaluation and optimization of the ADME, Toxicity, and Pharmacokinetic properties of drug candidates early in the drug-discovery process.

Pharmaterials Ltd is a pharmaceutical contract service company with comprehensive expertise in salt selection, polymorphism, amorphous materials, pharmaceutical materials science and formulation development for oral, inhaled and parenteral routes of drug delivery, with MHRA approved cGMP manufacture and analytical services.

PII (Pharmaceutics International, Inc) is a multinational contract formulation development, Clinical Trial Materials (CTM), and commercial manufacturing company with corporate headquarters in Hunt Valley, Maryland, USA. Founded in 1994 PII can manufacture a wide range of dosage forms covering solid, semi-solid and aseptic filling. This service is complemented by full analytical and regulatory support.

Mitsui is a pharmaceutical intermediate process development and outsourcing consulting company.